• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性保守治疗后的晚期毒性反应:吞咽困难和口干]

[Late toxicity following primary conservative treatment : Dysphagia and xerostomia].

作者信息

Jensen A D, Langer C

机构信息

Klinik für Strahlentherapie, Universitätsklinikum Gießen und Marburg, Klinikstr. 33, 35392, Gießen, Deutschland.

FB 20 (Medizin), Philipps-Universität Marburg, Marburg, Deutschland.

出版信息

HNO. 2021 Apr;69(4):263-277. doi: 10.1007/s00106-020-00961-7. Epub 2020 Nov 12.

DOI:10.1007/s00106-020-00961-7
PMID:33180145
Abstract

Dysphagia and xerostomia are still among the most important acute and late side effects of radiotherapy. Technical developments over the past two decades have led to improved diagnostics and recognition as well as understanding of the causes of these side effects. Based on these findings and advances in both treatment planning and irradiation techniques, the incidence and severity of treatment-associated radiogenic late sequelae could be clearly reduced by the use of intensity-modulated radiotherapy (IMRT), which could contribute to marked long-term improvements in the quality of life in patients with head and neck cancer. Highly conformal techniques, such as proton therapy have the potential to further reduce treatment-associated side effects in head and neck oncology and are currently being prospectively tested within clinical trial protocols at several centers.

摘要

吞咽困难和口干仍然是放疗最重要的急慢性副作用。过去二十年的技术发展使得对这些副作用的诊断、识别以及病因的理解都有所改善。基于这些发现以及治疗计划和照射技术的进步,使用调强放疗(IMRT)可明显降低与治疗相关的放射性晚期后遗症的发生率和严重程度,这有助于显著长期改善头颈癌患者的生活质量。高度适形技术,如质子治疗,有可能进一步减少头颈肿瘤学中与治疗相关的副作用,目前多个中心正在临床试验方案中对其进行前瞻性测试。

相似文献

1
[Late toxicity following primary conservative treatment : Dysphagia and xerostomia].[原发性保守治疗后的晚期毒性反应:吞咽困难和口干]
HNO. 2021 Apr;69(4):263-277. doi: 10.1007/s00106-020-00961-7. Epub 2020 Nov 12.
2
IMRT for head and neck cancer: reducing xerostomia and dysphagia.头颈部癌的调强放射治疗:减少口干和吞咽困难。
J Radiat Res. 2016 Aug;57 Suppl 1(Suppl 1):i69-i75. doi: 10.1093/jrr/rrw047.
3
Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.头颈部放疗后出现严重的口干、吞咽困难和颈部纤维化。
Head Neck. 2019 Oct;41(10):3594-3603. doi: 10.1002/hed.25880. Epub 2019 Jul 22.
4
Evidence-based organ-sparing radiotherapy in head and neck cancer.头颈部癌症的循证器官保留放疗。
Lancet Oncol. 2010 Jan;11(1):85-91. doi: 10.1016/S1470-2045(09)70231-1.
5
Dysphagia in head and neck cancer patients treated with chemoradiotherapy.头颈部癌症患者放化疗后吞咽困难。
Dysphagia. 2010 Jun;25(2):139-52. doi: 10.1007/s00455-009-9247-7. Epub 2009 Aug 27.
6
Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer.调强适形放疗与三维适形放疗治疗头颈部癌症的两年和终生成本效益分析。
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):683-9. doi: 10.1016/j.ijrobp.2013.08.011.
7
Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results.比较三维适形放疗与调强放疗治疗头颈部鳞状细胞癌的前瞻性随机对照试验:长期结果
Head Neck. 2016 Apr;38 Suppl 1:E1481-7. doi: 10.1002/hed.24263. Epub 2015 Nov 11.
8
Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.调强放疗与三维适形放疗治疗口咽癌的毒性反应和结局:配对分析。
Technol Cancer Res Treat. 2013 Apr;12(2):123-30. doi: 10.7785/tcrt.2012.500305. Epub 2012 Oct 19.
9
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.调强放射治疗可降低放射诱导的发病率并改善健康相关生活质量:一项使用标准化随访方案的非随机前瞻性研究结果
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26.
10
Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.头颈部癌调强放疗或标准放疗后生活质量与口干症的配对病例对照研究:初步报告
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):725-31. doi: 10.1016/j.ijrobp.2005.02.045.

引用本文的文献

1
Evaluation of recurrence, mortality and treatment complications of oral squamous cell carcinoma in public health centers in Shiraz during 2010 to 2020.2010 年至 2020 年在设拉子公共卫生中心评估口腔鳞状细胞癌的复发、死亡率和治疗并发症。
BMC Oral Health. 2023 May 30;23(1):341. doi: 10.1186/s12903-023-03071-2.
2
Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM).SAMITAL在头颈部癌放化疗所致口腔黏膜炎防治中的作用:一项2期随机双盲安慰剂对照临床试验(ROSAM)
Cancers (Basel). 2022 Dec 15;14(24):6192. doi: 10.3390/cancers14246192.

本文引用的文献

1
Eliminating Postoperative Radiation to the Pathologically Node-Negative Neck: Long-Term Results of a Prospective Phase II Study.消除病理淋巴结阴性颈部的术后放疗:一项前瞻性 II 期研究的长期结果。
J Clin Oncol. 2019 Oct 1;37(28):2548-2555. doi: 10.1200/JCO.19.00186. Epub 2019 Jun 27.
2
Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.放疗后头颈部癌症患者口腔口干症状的患者自评和医生评估与口腔和唾液腺剂量分布的关系。
Acta Oncol. 2019 Oct;58(10):1366-1372. doi: 10.1080/0284186X.2019.1627413. Epub 2019 Jun 26.
3
PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue.
在舌鳞状细胞癌患者的放射治疗计划中,使用 PET/MRI 引导的 GTV 勾画。
Strahlenther Onkol. 2019 Sep;195(9):780-791. doi: 10.1007/s00066-019-01480-3. Epub 2019 Jun 18.
4
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.头颈部根治性放射治疗中淋巴结靶区选择:2019 更新版。
Radiother Oncol. 2019 May;134:1-9. doi: 10.1016/j.radonc.2019.01.018. Epub 2019 Jan 30.
5
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.修订版欧洲癌症研究与治疗组织头颈部癌症模块(EORTC QLQ-HN43)的国际验证:第四阶段。
Head Neck. 2019 Jun;41(6):1725-1737. doi: 10.1002/hed.25609. Epub 2019 Jan 12.
6
External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6 months after definitive radiotherapy for head and neck cancer.头颈部癌症根治性放疗后 6 个月管饲依赖的多因素正常组织并发症概率模型的外部验证。
Radiother Oncol. 2018 Nov;129(2):403-408. doi: 10.1016/j.radonc.2018.09.013. Epub 2018 Oct 6.
7
Clinical Trial Strategies to Compare Protons With Photons.质子与光子比较的临床试验策略。
Semin Radiat Oncol. 2018 Apr;28(2):79-87. doi: 10.1016/j.semradonc.2017.11.008.
8
Validation and Psychometric Properties of the German Version of the SWAL-QOL.《吞咽生活质量问卷》德文版的效度及心理测量学特性
Dysphagia. 2018 Aug;33(4):431-440. doi: 10.1007/s00455-017-9872-5. Epub 2018 Jan 8.
9
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.喉、下咽、口咽和口腔鳞状细胞癌的原发肿瘤临床靶区(CTV-P)勾画:AIRO、CACA、DAHANCA、EORTC、GEORCC、GORTEC、HKNPCSG、HNCIG、IAG-KHT、LPRHHT、NCIC CTG、NCRI、NRG Oncology、PHNS、SBRT、SOMERA、SRO、SSHNO、TROG 共识指南。
Radiother Oncol. 2018 Jan;126(1):3-24. doi: 10.1016/j.radonc.2017.10.016. Epub 2017 Nov 24.
10
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial.诱导 TPF 后同期放化疗与单纯同期放化疗治疗局部晚期头颈部鳞癌的 II-III 期随机对照临床研究。
Ann Oncol. 2017 Sep 1;28(9):2206-2212. doi: 10.1093/annonc/mdx299.